Anti‐infective Agents: The Example of Antibacterial Drug Leads

Infectious bacterial diseases remain an important worldwide problem, not only due to expanding antibiotic resistance but also the substantial decrease in novel anti‐infective agents reaching clinical development during the last few decades. Natural products, either as pure compounds or as standardiz...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Macedo, Maíra Bidart, Clais, Sofie, Lanckacker, Ellen, Maes, Louis, Lima, Emerson Silva, Cos, Paul
Format: Buchkapitel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 122
container_issue
container_start_page 109
container_title
container_volume
creator Macedo, Maíra Bidart
Clais, Sofie
Lanckacker, Ellen
Maes, Louis
Lima, Emerson Silva
Cos, Paul
description Infectious bacterial diseases remain an important worldwide problem, not only due to expanding antibiotic resistance but also the substantial decrease in novel anti‐infective agents reaching clinical development during the last few decades. Natural products, either as pure compounds or as standardized plant extracts, may provide unlimited opportunities for new antibacterial drug leads because of the unmatched availability of chemical diversity. Research on new plant‐based antibacterial agents should shift from the typical bacteriostatic or bactericidal activities to antivirulence or resistance‐modifying activities. For this, a number of pivotal quality standards need to be set at the level of bioassays and evaluation criteria.
doi_str_mv 10.1002/9781118930717.ch11
format Book Chapter
fullrecord <record><control><sourceid>wiley</sourceid><recordid>TN_cdi_wiley_ebooks_10_1002_9781118930717_ch11_ch11</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10.1002/9781118930717.ch11</sourcerecordid><originalsourceid>FETCH-LOGICAL-s238f-e62e9401e75b72cb7448b33938e0ad963c7dbc3f36be396184f1fb5503d5beaa3</originalsourceid><addsrcrecordid>eNptkE1KxEAQhVtEUMdcwFVfILErlaS7XRnG8QcCbsZ16E6qZ6IxGabj78ojeEZPolERFTf1oHjfg_cY2wcRgRDxgZYKAJRGIUFG1RJgg-1-f2CTBT8cidpmgfdXQghIM9CQ7bCjvBua1-eXpnNUDc0d8XxB3eAP-XxJfPZgblYt8d7x0WdNNdC6MS0_Xt8ueEGm9ntsy5nWU_ClE3Z5MptPz8Li4vR8mhehj1G5kLKYdCKAZGplXFmZJMoialQkTK0zrGRtK3SYWUKdgUocOJumAuvUkjE4YdFn7n3T0mNJtu-vffmrf_nUrMpxg3JVu3cA_wFAlONwf8APaDz4BsGeYDk</addsrcrecordid><sourcetype>Enrichment Source</sourcetype><iscdi>true</iscdi><recordtype>book_chapter</recordtype></control><display><type>book_chapter</type><title>Anti‐infective Agents: The Example of Antibacterial Drug Leads</title><source>eBooks on EBSCOhost</source><creator>Macedo, Maíra Bidart ; Clais, Sofie ; Lanckacker, Ellen ; Maes, Louis ; Lima, Emerson Silva ; Cos, Paul</creator><contributor>Jäger, Anna K ; Heinrich, Michael</contributor><creatorcontrib>Macedo, Maíra Bidart ; Clais, Sofie ; Lanckacker, Ellen ; Maes, Louis ; Lima, Emerson Silva ; Cos, Paul ; Jäger, Anna K ; Heinrich, Michael</creatorcontrib><description>Infectious bacterial diseases remain an important worldwide problem, not only due to expanding antibiotic resistance but also the substantial decrease in novel anti‐infective agents reaching clinical development during the last few decades. Natural products, either as pure compounds or as standardized plant extracts, may provide unlimited opportunities for new antibacterial drug leads because of the unmatched availability of chemical diversity. Research on new plant‐based antibacterial agents should shift from the typical bacteriostatic or bactericidal activities to antivirulence or resistance‐modifying activities. For this, a number of pivotal quality standards need to be set at the level of bioassays and evaluation criteria.</description><identifier>ISBN: 9781118930748</identifier><identifier>ISBN: 1118930746</identifier><identifier>EISBN: 1118930711</identifier><identifier>EISBN: 9781118930717</identifier><identifier>DOI: 10.1002/9781118930717.ch11</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>antibacterial ; anti‐infective ; biofilms ; resistance‐modifying agents ; virulence</subject><ispartof>Ethnopharmacology, 2015, p.109-122</ispartof><rights>Copyright © 2015 John Wiley &amp; Sons, Ltd</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,781,785,794,27930</link.rule.ids></links><search><contributor>Jäger, Anna K</contributor><contributor>Heinrich, Michael</contributor><creatorcontrib>Macedo, Maíra Bidart</creatorcontrib><creatorcontrib>Clais, Sofie</creatorcontrib><creatorcontrib>Lanckacker, Ellen</creatorcontrib><creatorcontrib>Maes, Louis</creatorcontrib><creatorcontrib>Lima, Emerson Silva</creatorcontrib><creatorcontrib>Cos, Paul</creatorcontrib><title>Anti‐infective Agents: The Example of Antibacterial Drug Leads</title><title>Ethnopharmacology</title><description>Infectious bacterial diseases remain an important worldwide problem, not only due to expanding antibiotic resistance but also the substantial decrease in novel anti‐infective agents reaching clinical development during the last few decades. Natural products, either as pure compounds or as standardized plant extracts, may provide unlimited opportunities for new antibacterial drug leads because of the unmatched availability of chemical diversity. Research on new plant‐based antibacterial agents should shift from the typical bacteriostatic or bactericidal activities to antivirulence or resistance‐modifying activities. For this, a number of pivotal quality standards need to be set at the level of bioassays and evaluation criteria.</description><subject>antibacterial</subject><subject>anti‐infective</subject><subject>biofilms</subject><subject>resistance‐modifying agents</subject><subject>virulence</subject><isbn>9781118930748</isbn><isbn>1118930746</isbn><isbn>1118930711</isbn><isbn>9781118930717</isbn><fulltext>true</fulltext><rsrctype>book_chapter</rsrctype><creationdate>2015</creationdate><recordtype>book_chapter</recordtype><sourceid/><recordid>eNptkE1KxEAQhVtEUMdcwFVfILErlaS7XRnG8QcCbsZ16E6qZ6IxGabj78ojeEZPolERFTf1oHjfg_cY2wcRgRDxgZYKAJRGIUFG1RJgg-1-f2CTBT8cidpmgfdXQghIM9CQ7bCjvBua1-eXpnNUDc0d8XxB3eAP-XxJfPZgblYt8d7x0WdNNdC6MS0_Xt8ueEGm9ntsy5nWU_ClE3Z5MptPz8Li4vR8mhehj1G5kLKYdCKAZGplXFmZJMoialQkTK0zrGRtK3SYWUKdgUocOJumAuvUkjE4YdFn7n3T0mNJtu-vffmrf_nUrMpxg3JVu3cA_wFAlONwf8APaDz4BsGeYDk</recordid><startdate>20150918</startdate><enddate>20150918</enddate><creator>Macedo, Maíra Bidart</creator><creator>Clais, Sofie</creator><creator>Lanckacker, Ellen</creator><creator>Maes, Louis</creator><creator>Lima, Emerson Silva</creator><creator>Cos, Paul</creator><general>John Wiley &amp; Sons, Ltd</general><scope/></search><sort><creationdate>20150918</creationdate><title>Anti‐infective Agents: The Example of Antibacterial Drug Leads</title><author>Macedo, Maíra Bidart ; Clais, Sofie ; Lanckacker, Ellen ; Maes, Louis ; Lima, Emerson Silva ; Cos, Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-s238f-e62e9401e75b72cb7448b33938e0ad963c7dbc3f36be396184f1fb5503d5beaa3</frbrgroupid><rsrctype>book_chapters</rsrctype><prefilter>book_chapters</prefilter><language>eng</language><creationdate>2015</creationdate><topic>antibacterial</topic><topic>anti‐infective</topic><topic>biofilms</topic><topic>resistance‐modifying agents</topic><topic>virulence</topic><toplevel>online_resources</toplevel><creatorcontrib>Macedo, Maíra Bidart</creatorcontrib><creatorcontrib>Clais, Sofie</creatorcontrib><creatorcontrib>Lanckacker, Ellen</creatorcontrib><creatorcontrib>Maes, Louis</creatorcontrib><creatorcontrib>Lima, Emerson Silva</creatorcontrib><creatorcontrib>Cos, Paul</creatorcontrib></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Macedo, Maíra Bidart</au><au>Clais, Sofie</au><au>Lanckacker, Ellen</au><au>Maes, Louis</au><au>Lima, Emerson Silva</au><au>Cos, Paul</au><au>Jäger, Anna K</au><au>Heinrich, Michael</au><format>book</format><genre>bookitem</genre><ristype>CHAP</ristype><atitle>Anti‐infective Agents: The Example of Antibacterial Drug Leads</atitle><btitle>Ethnopharmacology</btitle><date>2015-09-18</date><risdate>2015</risdate><spage>109</spage><epage>122</epage><pages>109-122</pages><isbn>9781118930748</isbn><isbn>1118930746</isbn><eisbn>1118930711</eisbn><eisbn>9781118930717</eisbn><abstract>Infectious bacterial diseases remain an important worldwide problem, not only due to expanding antibiotic resistance but also the substantial decrease in novel anti‐infective agents reaching clinical development during the last few decades. Natural products, either as pure compounds or as standardized plant extracts, may provide unlimited opportunities for new antibacterial drug leads because of the unmatched availability of chemical diversity. Research on new plant‐based antibacterial agents should shift from the typical bacteriostatic or bactericidal activities to antivirulence or resistance‐modifying activities. For this, a number of pivotal quality standards need to be set at the level of bioassays and evaluation criteria.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><doi>10.1002/9781118930717.ch11</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISBN: 9781118930748
ispartof Ethnopharmacology, 2015, p.109-122
issn
language eng
recordid cdi_wiley_ebooks_10_1002_9781118930717_ch11_ch11
source eBooks on EBSCOhost
subjects antibacterial
anti‐infective
biofilms
resistance‐modifying agents
virulence
title Anti‐infective Agents: The Example of Antibacterial Drug Leads
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T21%3A51%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=bookitem&rft.atitle=Anti%E2%80%90infective%20Agents:%20The%20Example%20of%20Antibacterial%20Drug%20Leads&rft.btitle=Ethnopharmacology&rft.au=Macedo,%20Ma%C3%ADra%20Bidart&rft.date=2015-09-18&rft.spage=109&rft.epage=122&rft.pages=109-122&rft.isbn=9781118930748&rft.isbn_list=1118930746&rft_id=info:doi/10.1002/9781118930717.ch11&rft_dat=%3Cwiley%3E10.1002/9781118930717.ch11%3C/wiley%3E%3Curl%3E%3C/url%3E&rft.eisbn=1118930711&rft.eisbn_list=9781118930717&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true